Cleared Traditional

K233724 - 28mm/38D MDM X3 Insert for MDM Liner

K233724 is the FDA 510(k) clearance for 28mm/38D MDM X3 Insert for MDM Liner by Howmedica Osteonics Corp., Dba Stryker Orthopaedics. It is a Class 2 Orthopedic device (product code LZO) cleared through the Traditional 510(k) pathway after a 111-day FDA review.

K233724 · Howmedica Osteonics Corp., Dba Stryker Orthopaedics · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2024
Decision
111d
Days
Class 2
Risk

K233724 is an FDA 510(k) clearance for the 28mm/38D MDM X3 Insert for MDM Liner. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Howmedica Osteonics Corp., Dba Stryker Orthopaedics (Mahwah, US). The FDA issued a Cleared decision on March 11, 2024 after a review of 111 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Howmedica Osteonics Corp., Dba Stryker Orthopaedics devices

Submission Details

510(k) Number K233724 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 21, 2023
Decision Date March 11, 2024
Days to Decision 111 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d faster than avg
Panel avg: 122d · This submission: 111d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 419
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K233724.
EcoFit® short stem cementless cpTi
K240834 · Implantcast GmbH · Jun 2024
22.2mm BIOLOX® delta Ceramic V40™ Femoral Heads
K234025 · Howmedica Osteonics Corp., Dba Stryker Orthopaedics · Apr 2024
Ceramic Femoral Head
K240452 · Microport Orthopedics, Inc. · Apr 2024
Z1 Hip System
K233476 · Orchard Medical Development · Feb 2024
Novae® Dual Mobility System, Hype® Hip System
K223745 · Serf · Dec 2023
Actinia® hip stems
K232371 · Implantcast GmbH · Oct 2023